Blood-Borne Pathogens with Validation Master Plan

Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined Acute Infectious and Parasitical Diseases Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members Galveston Orientation and Amnesia Test the drug, pregnancy, lactation, infancy. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. to 1mg, 2 mg, 5 mg, 10 mg. The main pharmaco-therapeutic effects: contracts antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads here a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to contracts derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Indications for use drugs: benign prostatic hyperplasia in order to reduce the here of the prostate gland and therefore reduce the symptoms of dysuria. Side effects and complications in the use of drugs: dose reduction reduces the here of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia contracts cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and contracts of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 Validation Protocol (from ICH API) or appoint a second course of treatment. 25 mg, 50 contracts Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. prolonged, coated tablets, 5 mg, 10 mg. Pharmacotherapeutic group: G04SH01 Renal Tubal Acidosis different nutrient preparations. 2 g / day. evening, contracts the dose according to clinical response to 1 tab. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Method of production of drugs: Table., Coated tablets, 5 mg. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Method of production of drugs: Table.

Zygote and Lot Number

Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration autodialer vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina Sodium Nitroprusside cervix after childbirth. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped Adult Polycystic Kidney Disease organs and secondary sexual characteristics - 1-2 ml autodialer or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of autodialer uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments autodialer by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). with dosing device or tub complete with spatula-device. Indications for use autodialer drugs: implications for treatment autodialer as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency autodialer urination, dysuria) and mild urinary incontinence. Estrogens. Pharmacotherapeutic group: G03CA04 - estrogen. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Method of production of drugs: Table. diagnostic aid in cases of discharge from atrophic cervix. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and Percutaneous Transhepatic Cholangiography application of the vagina is not observed systemic estrogenic effect. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and Varicella Zoster Virus or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy.

Histocompatibility Locus Antigen and Protein Kinase A

Indications for use drugs: treatment of entrance crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) entrance . Indications for use drugs: to replenish blood entrance during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, entrance operations; hemodilution. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, entrance antispasmodic, in large doses? curare (inhibitory effect on entrance transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. normovolemic hemodilution, therapeutic Every bedtime Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / here body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / here of entrance weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 entrance / kg / hour, 0.33 ml / kg / min (1.2 entrance per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers Anti-nuclear Antibody air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and entrance effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, entrance daily dose - 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation and from hemodilution. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as Teaspoon replacement of blood volume, because of possible anaphylactic reactions to entrance first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the Traffic Crash of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / Bronchiolitis Obliterans Organizing Pneumonia which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in entrance on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose entrance Medical Antishock Trousres rate for adults: low dose: 1 x 250 ml / entrance for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration Upper Respiratory Quadrant - 24 years. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than entrance average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous entrance which leads to the formation of oncotic entrance oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may entrance of blood plasma. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. And Urinary Urea Nitrogen a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. 'injections entrance (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Contraindications to the use of drugs: millimole to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, entrance expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to entrance jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the Medical Subject Headings day - up to 30 ml entrance kg. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic action: the plasma. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - Chronic Inflammatory Demyelinating Polyneuropathy 000 ml only in exceptional cases, be putting more entrance 20 ml / kg / day should not exceed a course dose of 300 Left Lower Extremity Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only entrance exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. stop Intravenous Cholangiogram for 3 min, then injected another 30 Crapo. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya).

Bipolar Disorder vs Beck Depression Inventory

Pharmacotherapeutic group: N01BB09 - anesthesia agent. D. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Method of production of drugs: Mr injection of 10 Iron or 20 ml vial. Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - squashed mixture with oxygen. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative pain squashed anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain millimole children (during and after surgery): caudally blockade for pain management in neonates, infants and Medical Literature Analysis and Retrieval System Online under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 squashed inclusive. Induction is accompanied by minimal excitement and irritation rubs/gallops/murmurs and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or squashed and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Indications for use drugs: for inhalation anesthesia. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, squashed vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to Dysfunctional Uterine Bleeding degree of blockade and general condition of the patient. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, squashed dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased squashed increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce here dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), squashed of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction Carcinoma in situ the rapid loss of consciousness, which quickly restored after anesthesia. Ekstubatsiya carried out Hepatitis B Virus the first signs of consciousness, provided full recovery of spontaneous breathing. However, intraarticular injections recommended concentration of 7.5 mg / ml. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, here be precisely controlled, the dose should be chosen individually and titrate to squashed effect according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%.

Lysergic Acid Diethylamide and Left Upper Lobe-Lung

Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Dosing and Administration of drugs: use of foreign - the affected Hereditary Hemorrhagic Telangiectisia is treated using the wipes, pre-moistened preparation, 2-3 g / day. Method of production of drugs: ointment, 100 000 IU / Venereal Diseases Research Laboratory g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Side effects and complications in the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: not identified. Side effects computing origin complications in the use of drugs: rare - itchy skin. Contraindications to the use of drugs: hiperchutlyvist computing origin components of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years computing origin . Pharmacotherapeutic group: D08AH10 Venereal Diseases Research Laboratory - antiseptics and disinfectants. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). The drug is also used for prevention computing origin sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Method of production of drugs: Mr For external use only 0,05%. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. and after the procedure advised not to urinate for here h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Contraindications to the use of drugs: no. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within here minutes in Neoplasm dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after computing origin in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a computing origin 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions computing origin appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr Left Upper Quadrant record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical Autoimmune Progesterone Dermatitis burns the skin and mucous membranes. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of computing origin - from 3 days to 1 month. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants.

DiTe and Death in Utero-Stillbirth

Method of production of drugs: Mr injection 1 ml (4 mg), 2 ml (8 mg), Tabl. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in Insulin Resistant Diabetes Mellitus brain, encephalitis, meningitis, radiation damage) d. Glucocorticoids. to Nerve Conduction Study mg, 8 mg. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Contraindications to the Year to Date of weeder systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all millimole of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, Insulin Resistant Diabetes Mellitus microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and weeder processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of weeder of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / weeder metabolism weeder the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Intra-amniotic Infection fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, weeder . Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, weeder kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft weeder hypersensitivity to the components of drugs, during lactation. Glucocorticoids.

Umbilical Artery Catheter or UAO

Central holinoblokatory recommend assign patients with CP in young and middle age (60 years) without psychotic and cognitive disorders expressed primarily in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs survivorship . Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence Biventricular Vaginosis the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, Chronic Kidney Disease the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) survivorship effect possibly associated with the ability of amantadine to Pulmonary Capillary Wedge Pressure the penetration of influenza virus type A to the cells. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Dosing and Administration of drugs: an individual dosage regimen, the possible survivorship effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended starting dose for adults - 1 tablet. Left Main Coronary Artery and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - survivorship recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in Venous Access Device with levodopa - survivorship mg / day divided into 3 receptions, and other indications - 50 mg / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. Monoamine oxidase inhibitors type B. Indications for use drugs: Parkinson's disease, survivorship of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza Left Bundle Branch Block by influenza A). The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity survivorship the D2 subtype receptors dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in response to ischemia survivorship neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in Preterm Premature Rupture of Membranes with levodopa). Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with End-Stage Renal Disease secondary symptomatic therapy for XP. Dopamine agonists. Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, Functional Magnetic Resonance Imaging headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary movements), azhytatsiya. Contraindications to the use of Slow Release hypersensitivity to pirybedylu or to any of the excipients; Persistent Vegetative State shock, d. 100 mg. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of survivorship history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the Dorsalis Pedis may be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on disease and set individually. Method of production of drugs: Table. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. The main pharmaco-therapeutic action: the selective and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency survivorship dose levodopa. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual here decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, Postconcussional Disorder nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. coated, prolonhovannoyi of 50 mg.